Lite Strategy LITS
NASDAQ LITS
$1.18 -0.06 (-4.44%)
As of: Oct 22, 2026 · 10:51 AM EDT

Lite Strategy (LITS) Non-Current Deffered Revenue (2016 - 2023)

Updated

Lite Strategy (LITS) posted Non-Current Deffered Revenue of $64.55 million for fiscal Q4 2023 (quarter ended Jun 30, 2023), down 28.8% from $90.61 million a year earlier and unchanged from the prior quarter.

Analysis

Lite Strategy (LITS) Non-Current Deffered Revenue (2016 - 2023) Analysis & Trends

Since fiscal Q1 2017, Lite Strategy has reported Non-Current Deffered Revenue for 20 quarters.

  • Annual Non-Current Deffered Revenue shows a four-year compound annual growth rate of 118.7% (FY2019 to FY2023).
  • In prior fiscal years, Lite Strategy's Non-Current Deffered Revenue was $90.61 million in FY2022 (+21.3%), $74.7 million in FY2021 (-4.8%), $78.43 million in FY2020 and $2.82 million in FY2019.
  • Quarterly Non-Current Deffered Revenue has run from a low of $2.82 million in fiscal Q3 2020 to a high of $94.33 million in fiscal Q1 2022 over five years.
  • On a year-over-year basis, Non-Current Deffered Revenue has declined in each of the last four quarters, with growth averaging 0.3% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was fiscal Q3 2022, with growth of 30.0%; the weakest was fiscal Q2 2020, with a decline of 39.8%.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior fiscal quarters was $64.55 million (Q3 2023), $64.55 million (Q2 2023) and $89.97 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn -
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn -
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn -
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn -
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn -
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -
10 Lite Strategy 40.95 Mn 8.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 64.55 Mn
Mar 31, 2023 64.55 Mn
Dec 31, 2022 64.55 Mn
Sep 30, 2022 89.97 Mn
Jun 30, 2022 90.61 Mn
Mar 31, 2022 91.92 Mn
Dec 31, 2021 92.29 Mn
Sep 30, 2021 94.33 Mn
Jun 30, 2021 74.70 Mn
Mar 31, 2021 70.73 Mn
Dec 31, 2020 75.51 Mn
Sep 30, 2020 76.98 Mn
Jun 30, 2020 78.43 Mn
Mar 31, 2020 2.82 Mn
Dec 31, 2019 3.11 Mn
Sep 30, 2019 3.23 Mn
Jun 30, 2019 2.82 Mn
Mar 31, 2019 4.22 Mn
Dec 31, 2018 5.16 Mn
Sep 30, 2016 1.49 Mn
API Access

Lite Strategy Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=LITS&period=max&api_key=YOUR_API_KEY